Internal Server Error

Eyedaptic - About the company

Eyedaptic is a seed company based in Laguna Niguel (United States), founded in 2016. It operates as a Smart glasses enhancing vision for macular degeneration and low vision. Eyedaptic has raised $1.47M in funding, with a current valuation of $*****. The company has 48 active competitors, including 13 funded and 7 that have exited. Its top competitors include companies like Neurotech, Cerevast and Second Sight.

Company Details

Smart glasses enhancing vision for macular degeneration and low vision. They are dedicated to enhancing vision and revitalizing life for individuals with low vision. They offer smart glasses designed to make everyday tasks easier and improve the quality of life for those with Age-Related Macular Degeneration, Diabetic Retinopathy, and other central vision loss conditions. Their premier solution optimizes remaining vision with revolutionary, patented software. They leverage augmented reality (AR) and artificial intelligence (AI) technology to develop software-driven smart glasses. They also offer a Generative AI Visual Assistant, providing visual assistance. Their products aim to improve the vision of those suffering from retinal disorders. They are a B2C company with a social impact business model.
Registered Address
23421 South Pointe Drive, Laguna Hills, CA
Key Metrics
Founded Year
2016
Location
Laguna Niguel, United States
Stage
Seed
Total Funding
$1.47M in 4 rounds
Latest Funding Round
Post Money Valuation
$***** as on Oct 06, 2022
Ranked
Annual Revenue
$0 - $1M as on Dec 31, 2023
Employee Count
9 as on Oct 31, 2026
Similar Companies
Sign up to download Eyedaptic's company profile

Eyedaptic's funding and investors

Eyedaptic has raised a total funding of $1.47M over 4 rounds. Its first funding round was on Aug 30, 2017. Eyedaptic has 4 institutional investors.

Here is the list of recent funding rounds of Eyedaptic:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 26, 2021
6748854
Seed
3186837
2570336
8618625
2981778
Dec 19, 2019
1132549
Seed
9150497
1223929
9297852
1841868
May 15, 2018
4545808
Seed
4991784
6732896
5421471
5757764
lockAccess funding benchmarks and valuations. Sign up today!

Eyedaptic's founders and board of directors

Founder? Claim Profile

Eyedaptic's employee count trend

Eyedaptic has 9 employees as of Oct 26. Here is Eyedaptic's employee count trend over the years:
Employee count trend for Eyedaptic
lockUncover Eyedaptic's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Eyedaptic's Competitors and alternates

Top competitors of Eyedaptic include Neurotech, Cerevast and Second Sight. Here is the list of Top 10 competitors of Eyedaptic, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Neurotech
Neurotech
2000, Cumberland (United States), Series B
Developer of a cell-based delivery device for the treatment of eye diseases
$53.3M
57/100
2nd
Logo for Eyedaptic
Eyedaptic
2016, Laguna Niguel (United States), Seed
Smart glasses enhancing vision for macular degeneration and low vision
$1.47M
50/100
3rd
Logo for Cerevast
Cerevast
2009, Bothell (United States), Series C
Medical device company developing innovative ultrasound and microsphere therapies
$46.9M
50/100
4th
Logo for Second Sight
Second Sight
2000, Los Angeles (United States), Public
Provider of an implantable visual prosthetic for blind individuals
$36.9M
49/100
5th
Logo for Maculaser
Maculaser
2018, Espoo (Finland), Seed
Developer of laser therapy for the treatment of retinal diseases
$1.45M
48/100
6th
Logo for RecensMedical
RecensMedical
2016, Ulsan (South Korea), Public
Developer of an anesthetic medical device for retinal diseases
-
48/100
7th
Logo for Pixium Vision
Pixium Vision
2011, Paris (France), Public
Provider of bionic vision restoration systems
$32.5M
46/100
8th
Logo for iScience Interventional
iScience Interventional
1999, Menlo Park (United States), Acquired
Innovative medical device company focused on interventional solutions
$36.7M
44/100
9th
Logo for Pykus Therapeutics
Pykus Therapeutics
2016, Boston (United States), Seed
Develops a dissolvable intraocular device for use during retinal surgery
$2.49M
38/100
10th
Innovating ophthalmic surgical devices to prevent blindness and improve global vision
$50M
37/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Eyedaptic's competitors? Click here to see the top ones

Eyedaptic's Investments and acquisitions

Eyedaptic has made no investments or acquisitions yet.

Reports related to Eyedaptic

Here is the latest report on Eyedaptic's sector:

News related to Eyedaptic

Media has covered Eyedaptic for a total of 2 events in the last 1 year, 2 of them have been about company updates.
•
Eyedaptic Unveils EYE7 Smart GlassesEyewire News•Mar 25, 2026•Eyedaptic
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Eyedaptic

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford